Alena Stančáková1, Teemu Kuulasmaa1, Johanna Kuusisto1,2, Karen L Mohlke3, Francis S Collins4, Michael Boehnke5, Markku Laakso6,7. 1. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Yliopistonranta 1 B, 70210, Kuopio, Finland. 2. Department of Medicine, Kuopio University Hospital, Kuopio, Finland. 3. Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. 4. National Human Genome Research Institute, National Institutes for Health (NIH), Bethesda, MD, USA. 5. Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA. 6. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Yliopistonranta 1 B, 70210, Kuopio, Finland. markku.laakso@uef.fi. 7. Department of Medicine, Kuopio University Hospital, Kuopio, Finland. markku.laakso@uef.fi.
Abstract
AIMS/HYPOTHESIS: Many SNPs have been associated with glycaemic traits and type 2 diabetes, but their joint effects on glycaemic traits and the underlying mechanisms leading to hyperglycaemia over time are largely unknown. We aimed to investigate the association of six genetic risk scores (GRSs) with changes in plasma glucose, insulin sensitivity, insulin secretion and incident type 2 diabetes in the prospective METabolic Syndrome In Men (METSIM) study. METHODS: We generated weighted GRSs for fasting plasma glucose ([FPG] GRSFPG, 35 SNPs), 2 h plasma glucose ([2hPG] GRS2hPG, 9 SNPs), insulin secretion (GRSIS, 17 SNPs), insulin resistance (GRSIR, 9 SNPs) and BMI (GRSBMI, 95 SNPs) and a non-weighted GRS for type 2 diabetes (GRST2D, 76 SNPs) in up to 8749 non-diabetic Finnish men. Linear regression was used to test associations of the GRSs with changes in glycaemic traits over time. RESULTS: GRST2D, GRSFPG and GRSIS were associated with an increase in FPG, GRST2D with an increase in glucose AUC and a decrease in insulin secretion, and GRS2hPG with an increase in 2hPG during the follow-up (p < 0.0017 for all models). GRST2D, GRSFPG and GRSIS were associated with incident type 2 diabetes (p < 0.008 for all models). GRSBMI and GRSIR were not significantly associated with any changes in glycaemic traits. CONCLUSIONS/ INTERPRETATION: In the METSIM follow-up study, GRST2D, GRSFPG and GRSIS were associated with the worsening of FPG and an increase in incident type 2 diabetes. GRST2D was additionally associated with a decrease in insulin secretion, and GRS2hPG with an increase in 2hPG.
AIMS/HYPOTHESIS: Many SNPs have been associated with glycaemic traits and type 2 diabetes, but their joint effects on glycaemic traits and the underlying mechanisms leading to hyperglycaemia over time are largely unknown. We aimed to investigate the association of six genetic risk scores (GRSs) with changes in plasma glucose, insulin sensitivity, insulin secretion and incident type 2 diabetes in the prospective METabolic Syndrome In Men (METSIM) study. METHODS: We generated weighted GRSs for fasting plasma glucose ([FPG] GRSFPG, 35 SNPs), 2 h plasma glucose ([2hPG] GRS2hPG, 9 SNPs), insulin secretion (GRSIS, 17 SNPs), insulin resistance (GRSIR, 9 SNPs) and BMI (GRSBMI, 95 SNPs) and a non-weighted GRS for type 2 diabetes (GRST2D, 76 SNPs) in up to 8749 non-diabetic Finnish men. Linear regression was used to test associations of the GRSs with changes in glycaemic traits over time. RESULTS: GRST2D, GRSFPG and GRSIS were associated with an increase in FPG, GRST2D with an increase in glucose AUC and a decrease in insulin secretion, and GRS2hPG with an increase in 2hPG during the follow-up (p < 0.0017 for all models). GRST2D, GRSFPG and GRSIS were associated with incident type 2 diabetes (p < 0.008 for all models). GRSBMI and GRSIR were not significantly associated with any changes in glycaemic traits. CONCLUSIONS/ INTERPRETATION: In the METSIM follow-up study, GRST2D, GRSFPG and GRSIS were associated with the worsening of FPG and an increase in incident type 2 diabetes. GRST2D was additionally associated with a decrease in insulin secretion, and GRS2hPG with an increase in 2hPG.
Authors: George Alberti; Paul Zimmet; Jonathan Shaw; Zachary Bloomgarden; Francine Kaufman; Martin Silink Journal: Diabetes Care Date: 2004-07 Impact factor: 19.112
Authors: Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker Journal: Bioinformatics Date: 2008-10-30 Impact factor: 6.937
Authors: Philippa J Talmud; Aroon D Hingorani; Jackie A Cooper; Michael G Marmot; Eric J Brunner; Meena Kumari; Mika Kivimäki; Steve E Humphries Journal: BMJ Date: 2010-01-14
Authors: Jason L Vassy; Marie-France Hivert; Bianca Porneala; Marco Dauriz; Jose C Florez; Josée Dupuis; David S Siscovick; Myriam Fornage; Laura J Rasmussen-Torvik; Claude Bouchard; James B Meigs Journal: Diabetes Date: 2014-02-11 Impact factor: 9.337
Authors: Melis A Aksit; Rhonda G Pace; Briana Vecchio-Pagán; Hua Ling; Johanna M Rommens; Pierre-Yves Boelle; Loic Guillot; Karen S Raraigh; Elizabeth Pugh; Peng Zhang; Lisa J Strug; Mitch L Drumm; Michael R Knowles; Garry R Cutting; Harriet Corvol; Scott M Blackman Journal: J Clin Endocrinol Metab Date: 2020-05-01 Impact factor: 5.958
Authors: América Liliana Miranda-Lora; Jenny Vilchis-Gil; Daniel B Juárez-Comboni; Miguel Cruz; Miguel Klünder-Klünder Journal: Front Endocrinol (Lausanne) Date: 2021-03-12 Impact factor: 5.555
Authors: Fariba Ahmadizar; Carolina Ochoa-Rosales; Marija Glisic; Oscar H Franco; Taulant Muka; Bruno H Stricker Journal: Br J Clin Pharmacol Date: 2019-03-18 Impact factor: 4.335
Authors: Maggie A Stanislawski; Elizabeth Litkowski; Sridharan Raghavan; Kylie K Harrall; Jessica Shaw; Deborah H Glueck; Ethan M Lange; Dana Dabelea; Leslie A Lange Journal: Diabetes Care Date: 2021-07-13 Impact factor: 17.152
Authors: Steven E Kahn; Yi-Chun Chen; Nathalie Esser; Austin J Taylor; Daniël H van Raalte; Sakeneh Zraika; C Bruce Verchere Journal: Endocr Rev Date: 2021-09-28 Impact factor: 25.261
Authors: Camille E Powe; Michael Nodzenski; Octavious Talbot; Catherine Allard; Catherine Briggs; Marysa V Leya; Patrice Perron; Luigi Bouchard; Jose C Florez; Denise M Scholtens; William L Lowe; Marie-France Hivert Journal: Diabetes Date: 2018-09-26 Impact factor: 9.461